Investor Presentaiton

Summary Quarterly Performance Revenues 1,029 1,425 [Cr] EBITDA & Margins % 29.5% 1,539 1,576 28.2% 27.9% 28.5% 1,545 26.1% 1,381 20.8% 454 1,182 1,224 449 15.4% 398 404 14.2% 290 287 188 168 3Q FY22 4Q 1Q FY22 FY23 2Q FY23 3Q 4Q FY23 FY23 1Q FY24 2Q FY24 ROCE^ % 17 25.9% 23.7% 22.7% 22.7% 22.7% 21.3% 15.9% 11.4% 3Q 4Q FY22 FY22 FY23 1Q 2Q FY23 3Q 4Q 1Q 2Q FY23 FY23 FY24 FY24 Net Leverage* 1.9x 1.6x 1.3x 1.3x 1.3x 1.2x 1.2x 1.2x Net Debt-to-EBITDA 3Q FY22 4Q 1Q 2Q FY22 FY23 FY23 3Q FY23 4Q 1Q FY23 FY24 2Q FY24 3Q FY22 4Q FY22 1Q Q2 Q3 Q4 FY23 FY23 FY23 FY23 Q1 FY24 Q2 FY24 ^ EBIT (TTM)/Capital Employed Laurus Q2 & H1 FY 2024 Investor Presentation | October 20, 2023 * Net Debt/EBIDTA (TTM) [Cr] LAURUS Labs Knowledge. Innovation. Excellence

View entire presentation